Ardent Health (NYSE:ARDT) Given New $13.00 Price Target at Truist Financial

Ardent Health (NYSE:ARDT) had its target price cut by Truist Financial from $21.00 to $13.00 in a research report sent to investors on Friday, MarketBeat reports. They currently have a buy rating on the stock.

Other equities analysts have also issued research reports about the company. Weiss Ratings raised Ardent Health from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, October 24th. KeyCorp cut their price target on Ardent Health from $24.00 to $20.00 and set an “overweight” rating for the company in a research note on Thursday, August 7th. Royal Bank Of Canada reduced their price target on Ardent Health from $21.00 to $16.00 and set an “outperform” rating for the company in a report on Friday. Bank of America reduced their price target on shares of Ardent Health from $12.00 to $10.00 and set an “underperform” rating for the company in a research report on Thursday. Finally, JPMorgan Chase & Co. cut their target price on shares of Ardent Health from $18.00 to $15.00 and set a “neutral” rating for the company in a research report on Monday, August 11th. Seven research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $15.92.

Ardent Health Stock Performance

Shares of NYSE:ARDT traded down $0.27 during midday trading on Friday, reaching $9.04. The company’s stock had a trading volume of 1,914,573 shares, compared to its average volume of 512,810. The firm has a market capitalization of $1.29 billion, a PE ratio of 6.23, a P/E/G ratio of 7.98 and a beta of 0.44. The stock has a fifty day moving average of $13.80 and a 200 day moving average of $13.34. The company has a quick ratio of 2.00, a current ratio of 2.13 and a debt-to-equity ratio of 0.66. Ardent Health has a twelve month low of $8.85 and a twelve month high of $17.91.

Ardent Health (NYSE:ARDT) last announced its earnings results on Wednesday, November 12th. The company reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.42 by $0.10. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.55 billion. Ardent Health had a net margin of 3.24% and a return on equity of 19.19%. Ardent Health has set its FY 2025 guidance at 0.850-1.030 EPS. On average, equities analysts expect that Ardent Health will post 1.23 EPS for the current fiscal year.

Hedge Funds Weigh In On Ardent Health

A number of institutional investors have recently bought and sold shares of ARDT. Hotchkis & Wiley Capital Management LLC acquired a new position in shares of Ardent Health in the third quarter worth $6,377,000. Zurcher Kantonalbank Zurich Cantonalbank bought a new stake in shares of Ardent Health in the third quarter valued at approximately $61,000. Bridgeway Capital Management LLC acquired a new position in shares of Ardent Health during the third quarter valued at about $6,024,000. Squarepoint Ops LLC bought a new stake in shares of Ardent Health during the third quarter valued at approximately $145,000. Finally, Comerica Bank raised its stake in shares of Ardent Health by 24.9% in the 3rd quarter. Comerica Bank now owns 23,579 shares of the company’s stock valued at $312,000 after buying an additional 4,703 shares in the last quarter.

About Ardent Health

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.